Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AORTIC 2017 /
Globocan and cancer registry data

7th - 10th Nov 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.11.17
Views: 1361

Dr Max Parkin - African Cancer Registry Network and University of Oxford, UK

Dr Parkin speaks with ecancer at AORTIC 2017 about building a more comprehensive understanding of global cancer burden with Globocan and registry data.

He goes on to consider time to diagnosis, with many cancers only being detected in their advanced stages.

Dr Parkin also spoke with ecancer about UICC staging guidelines, here.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation